Royal Bank Of Canada Regencell Bioscience Holdings LTD Transaction History
Royal Bank Of Canada
- $458 Billion
- Q1 2025
A detailed history of Royal Bank Of Canada transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 948 shares of RGC stock, worth $16,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
948Holding current value
$16,495% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGC
# of Institutions
6Shares Held
8.71KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA6.82KShares$118,5980.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY698Shares$12,1450.0% of portfolio
-
Black Rock Inc. New York, NY238Shares$4,1410.0% of portfolio
-
Morgan Stanley New York, NY5Shares$870.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $226M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...